What Is 25-hydroxycholesterol 7α-hydroxylase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 25-hydroxycholesterol 7α-hydroxylase, also known as CYP7B1, is a cytochrome P450 enzyme encoded by the CYP7B1 gene in humans, primarily involved in the metabolism of oxysterols and neurosteroids. It catalyzes the 7α-hydroxylation of 25-hydroxycholesterol, a key step in the alternative bile acid synthesis pathway. Mutations in CYP7B1 are linked to neurological disorders such as SPG5, a form of hereditary spastic paraplegia.

Key Facts

CYP7B1 is encoded by the CYP7B1 gene located on chromosome 8q21.3
The enzyme catalyzes the 7α-hydroxylation of 25-hydroxycholesterol with a Km of ~5 μM
First identified in human liver microsomes in 1989
CYP7B1 mutations are associated with SPG5, diagnosed in ~1% of hereditary spastic paraplegia cases
The enzyme also metabolizes dehydroepiandrosterone (DHEA) and other neurosteroids

Overview

25-hydroxycholesterol 7α-hydroxylase, officially designated as CYP7B1, is a member of the cytochrome P450 superfamily of enzymes. It plays a pivotal role in the oxidation of sterols, particularly in initiating the conversion of cholesterol derivatives into bile acids via the acidic (alternative) pathway.

This enzyme is expressed in multiple tissues, including the liver, brain, and prostate, indicating its broad physiological significance. Its activity helps regulate cholesterol homeostasis and influences neurosteroid levels, which are critical for neurological function.

CYP7B1 catalyzes the 7α-hydroxylation of 25-hydroxycholesterol, a reaction essential for bile acid synthesis outside the classical pathway.
The enzyme exhibits high specificity for oxysterols, with 25-hydroxycholesterol as its primary substrate and a measured Km of approximately 5 μM.
It is encoded by the CYP7B1 gene, located on human chromosome 8q21.3, and spans over 10 exons.
CYP7B1 was first isolated and characterized in human liver microsomes in 1989, marking a milestone in understanding alternative bile acid formation.
Expression levels vary by tissue, with significant activity detected in the brain, liver, and prostate glands, suggesting diverse metabolic roles.

How It Works

CYP7B1 functions as a monooxygenase, using molecular oxygen and NADPH to introduce a hydroxyl group at the 7α position of sterol substrates. This biochemical transformation is crucial for solubilizing cholesterol derivatives and preparing them for further catabolism.

Substrate specificity: CYP7B1 primarily acts on 25-hydroxycholesterol but also metabolizes other oxysterols and neurosteroids like DHEA and pregnenolone.
Catalytic mechanism: The enzyme uses heme iron to activate oxygen, enabling insertion of a hydroxyl group at the 7α position of the steroid nucleus.
Gene regulation: CYP7B1 expression is regulated by liver X receptors (LXRs), which respond to elevated oxysterol levels in cells.
Tissue distribution: High expression in the liver supports bile acid synthesis, while brain expression links it to neurosteroid homeostasis.
Enzyme kinetics: Exhibits a Vmax of ~12 pmol/min/mg protein and Km of ~5 μM for 25-hydroxycholesterol in recombinant systems.
Pathway role: Serves as the first enzyme in the acidic pathway of bile acid synthesis, converting 25-hydroxycholesterol to 7α,25-dihydroxycholesterol.

Comparison at a Glance

Below is a comparison of CYP7B1 with related cytochrome P450 enzymes involved in sterol metabolism.

Enzyme	Gene	Primary Substrate	Function	Tissue Expression
CYP7B1	CYP7B1	25-hydroxycholesterol	7α-hydroxylation in acidic bile acid pathway	Liver, brain, prostate
CYP7A1	CYP7A1	Cholesterol	Rate-limiting step in classical bile acid synthesis	Liver
CYP27A1	CYP27A1	Cholesterol	27-hydroxylation leading to oxysterol formation	Ubiquitous
CYP46A1	CYP46A1	Cholesterol	24-hydroxylation in brain cholesterol elimination	Brain
CYP39A1	CYP39A1	24-hydroxycholesterol	7α-hydroxylation in bile acid synthesis	Liver

While CYP7A1 dominates bile acid synthesis in the liver, CYP7B1 provides a complementary pathway that becomes more significant under conditions where classical pathway enzymes are suppressed. Its broad substrate range and extrahepatic expression suggest roles beyond bile acid production, particularly in neuroprotection and inflammation regulation.

Why It Matters

Understanding CYP7B1 is essential for insights into cholesterol metabolism, neurological health, and potential therapeutic targets. Its dysfunction has direct clinical implications, particularly in rare genetic disorders.

Mutations in CYP7B1 cause SPG5, a subtype of hereditary spastic paraplegia, affecting ~1% of cases, typically presenting in adolescence.
Elevated levels of 25-hydroxycholesterol are observed in SPG5 patients due to impaired enzyme activity.
The enzyme’s role in neurosteroid metabolism links it to mood regulation, memory, and neurodegenerative diseases.
CYP7B1 activity influences inflammatory responses, as oxysterols modulate immune cell function via LXR signaling.
It is a potential target for drug development in neurodegenerative conditions and liver diseases.
Research into CYP7B1 helps clarify the alternative bile acid pathway, which may be upregulated in liver disease or CYP7A1 deficiency.

Given its dual roles in metabolic and neurological systems, CYP7B1 represents a critical intersection of endocrinology, neurology, and hepatology, warranting continued research and clinical attention.